Clinical Trial Update: The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients

View source ↗

Summary

A completed AstraZeneca-sponsored clinical trial update describing symptom control and impact on daily life in patients with gastroesophageal reflux disease (GE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED